Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses

1 Jun 2005

Abstract excerpt

We used a proteomic approach for identifying molecules involved in the pathogenesis of chronic lymphocytic leukemia (CLL). We investigated 14 patients who were completely concordant for IgV(H) mutational status (unmutated vs. mutated), CD38 expression (positive vs. negative), and clinical behavior (progressive vs. stable); these patients were characterized as having either poor or good prognoses. The 2 patient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Immunodeficiency and Autoimmune Disorders
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15931393
DOI: 10.1172/jci24276

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognosesPMID 15931393Read ↗

Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemiaSemantic proximity Read ↗

HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based RegimenSemantic proximity Read ↗

Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells.Semantic proximity Read ↗

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.Semantic proximity Read ↗

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.Semantic proximity Read ↗

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cellsSemantic proximity Read ↗

Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemiaSemantic proximity Read ↗

Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemiaSemantic proximity Read ↗

Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.Semantic proximity Read ↗

CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is notSemantic proximity Read ↗

Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia.Semantic proximity Read ↗

Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.